Cheng Chee, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Targeted Therapy
Royal Free Hospital and University College London Medical School
Medical School
Mayo School of Graduate Medical Education
Residency
Mayo School of Graduate Medical Education
Fellowship
American Board of Internal Medicine
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Oncology
MN State Medical License Active through 2012
OH State Medical License Active through 2015
Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas.
Chee CE Krishnamurthi S Nock CJ Meropol NJ Gibbons J Fu P Bokar J Teston L O'Brien T Gudena V Reese A Bergman M Saltzman J Wright JJ Dowlati A Brell J; Oncologist. 2013 .
See more >>Targeted therapeutic agents for colorectal cancer.
Chee, C.E., Sinicrope, F.A.; Gastroenterol Clin North Am. 2010 Sep
See more >>Reduction in plasma cell proliferation after initial therapy in newly diagnosed multiple myeloma measures treatment response and predicts improved survival.
Larsen, J.T., Chee, C.E., Lust, J.A., Greipp, P.R., Rajkumar, S.V.; Blood. 2011 Sep 8.
See more >>